Experimental groups
Animals were allocated to two experimental groups: UVD (A) and labyrinthine intact (B).
Group No. | Cannula Site | Drug and Total Dose over 30-h Infusion Period | Sample Size |
|---|---|---|---|
| A1 | Ipsilateral VNC | 75 ng of muscimol | 5 |
| A2 | Ipsilateral VNC | 125 ng of muscimol | 5 |
| A3 | Ipsilateral VNC | 250 ng of muscimol | 5 |
| A4 | Ipsilateral VNC | 2 ng of NaOH | 5 |
| A5 | Ipsilateral VNC | 31.25 ng of gabazine | 5 |
| A6 | Ipsilateral VNC | 62.5 ng of gabazine | 5 |
| A7 | Ipsilateral VNC | 125 ng of gabazine | 5 |
| A8 | Ipsilateral VNC | Deionized water | 5 |
| A9 | Contralateral VNC | 250 ng of muscimol | 5 |
| A10 | Contralateral VNC | 400 ng of muscimol | 5 |
| A11 | Contralateral VNC | 750 ng of muscimol | 5 |
| A12 | Contralateral VNC | 8.1 ng of NaOH | 5 |
| A13 | Contralateral VNC | 125 ng of gabazine | 5 |
| A14 | Contralateral VNC | 375 ng of gabazine | 5 |
| A15 | Contralateral VNC | 750 ng of gabazine | 5 |
| A16 | Contralateral VNC | Deionized water | 5 |
| B1 | Ipsilateral VNC | 750 ng of muscimol | 4 |
| B2 | Ipsilateral VNC | 8.1 ng of NaOH | 4 |
| B3 | Ipsilateral VNC | 750 ng of gabazine | 4 |